跳至主要内容
临床试验/DRKS00028080
DRKS00028080招募中不适用

Contrast-enhanced ultrasound (CEUS) for assessment of perfusion patterns of musculoskeletal tumors - CEUS TUMOR

Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie0 个研究点目标入组 300 人开始时间: 2022年2月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Adult patients with a musculoskeletal tumor who are being treated surgically at the Heidelberg University Hospital are included in the study.

排除标准

  • Age under 18 years
  • Inability to consent
  • Known intolerance to SonoVue® or other ultrasound contrast media.
  • Severe heart failure (NYHA III and IV), right-to-left shunt in the heart, uncontrollable high blood pressure.
  • Severe pulmonary disease, particularly severe obstructive pulmonary disease, ARDS and severe pulmonary arterial hypertension.
  • Myocardial infarction within the last 14 days.
  • Disorders of the galactose metabolism (galactosemia).
  • Pregnancy and breast feeding period.
  • Lack of informed consent or refusal to participate.

研究者

发起方
Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie

相似试验